Stemline Therapeutics' Series A - II Round

Stemline Therapeutics raised a round of funding on April 20, 2010.

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology therapeutics that target cancer stem cells (CSCs) as well as the tumor bulk. Among Stemline's drug candidates ar…

Articles about Stemline Therapeutics' Series A - II Round: